---
title: "Jiangsu Apon Medical Technology Co.,Ltd. (300753.SZ)"
type: "Symbol"
locale: "en"
url: "https://longbridge.com/en/quote/300753.SZ.md"
symbol: "300753.SZ"
name: "Jiangsu Apon Medical Technology Co.,Ltd."
industry: "Health Care Equipment"
datetime: "2026-05-20T00:24:53.770Z"
locales:
  - [en](https://longbridge.com/en/quote/300753.SZ.md)
  - [zh-CN](https://longbridge.com/zh-CN/quote/300753.SZ.md)
  - [zh-HK](https://longbridge.com/zh-HK/quote/300753.SZ.md)
---

# Jiangsu Apon Medical Technology Co.,Ltd. (300753.SZ)

## Company Overview

Jiangsu Apon Medical Technology Co., Ltd. engages in the research and development, production, and sale of medical devices in China. The company’s principal products include microcomputer injection pumps, disposable injection pumps, wireless analgesia management systems, and pulse oximeters, as well as medical devices, such as sensors in the field of pain management and nasal care sprayers. Jiangsu Apon Medical Technology Co., Ltd.

| Item | Detail |
|------|--------|
| Industry | Health Care Equipment |
| Exchange | CN Market |
| Website | [www.apon.com.cn](https://www.apon.com.cn) |

## Key Drivers
> *AI-analyzed key factors driving this stock's performance*


## Longbridge Financial Score™: C
> *Longbridge Financial Score™ — Proprietary multi-factor rating model by Longbridge*
> Updated: 2026-05-19T04:30:08.000Z

**Overall: C (0.57)**

**Industry**: Health Care Equipment

| Metric | Value |
|--------|-------|
| Industry Ranking | 56 / 64 |
| Industry Median | C |
| Industry Average | C |

- **Style**: Blend - Stocks in which the company has both growth and mature businesses.
- **Scale**: Small - The company's operation has a high degree of growth and volatility, making it easy to achieve high investment returns.

**Multi Score**: C

#### Style Score Score: 

| Indicator | Value | Rating |
|-----------|-------|--------|
| Revenue YoY | -9.29% |  |
| Net Profit YoY | -31.16% |  |
| P/B Ratio | 5.13 |  |
| Dividend Ratio | 0.24% |  |

#### Size Score Score: 

| Indicator | Value | Rating |
|-----------|-------|--------|
| Market Cap | 3401305423.41 |  |
| Revenue | 345175353.38 |  |

#### Multi Score Score: C

| Indicator | Value | Rating |
|-----------|-------|--------|
| ROE | -1.60% | D |
| Profit Margin | -3.11% | D |
| Gross Margin | 66.18% | A |
| Revenue YoY | -9.29% | D |
| Net Profit YoY | -31.16% | D |
| Total Assets YoY | -3.63% | D |
| Net Assets YoY | -2.16% | D |
| Cash Flow Margin | -147.13% | E |
| OCF YoY | -9.29% | D |
| Turnover | 0.42 | C |
| Gearing Ratio | 17.29% | A |

```chart-data:radar
{
  "title": "Longbridge Financial Score - Jiangsu Apon Medical Technology Co.,Ltd.",
  "chart_type": "radar",
  "dimensions": [
    {
      "name": "Style Score",
      "grade": "",
      "indicators": [
        {
          "name": "Revenue YoY",
          "value": "-9.29%",
          "rating": ""
        },
        {
          "name": "Net Profit YoY",
          "value": "-31.16%",
          "rating": ""
        },
        {
          "name": "P/B Ratio",
          "value": "5.13",
          "rating": ""
        },
        {
          "name": "Dividend Ratio",
          "value": "0.24%",
          "rating": ""
        }
      ]
    },
    {
      "name": "Size Score",
      "grade": "",
      "indicators": [
        {
          "name": "Market Cap",
          "value": "3401305423.41",
          "rating": ""
        },
        {
          "name": "Revenue",
          "value": "345175353.38",
          "rating": ""
        }
      ]
    },
    {
      "name": "Multi Score",
      "grade": "C",
      "indicators": [
        {
          "name": "ROE",
          "value": "-1.60%",
          "rating": "D"
        },
        {
          "name": "Profit Margin",
          "value": "-3.11%",
          "rating": "D"
        },
        {
          "name": "Gross Margin",
          "value": "66.18%",
          "rating": "A"
        },
        {
          "name": "Revenue YoY",
          "value": "-9.29%",
          "rating": "D"
        },
        {
          "name": "Net Profit YoY",
          "value": "-31.16%",
          "rating": "D"
        },
        {
          "name": "Total Assets YoY",
          "value": "-3.63%",
          "rating": "D"
        },
        {
          "name": "Net Assets YoY",
          "value": "-2.16%",
          "rating": "D"
        },
        {
          "name": "Cash Flow Margin",
          "value": "-147.13%",
          "rating": "E"
        },
        {
          "name": "OCF YoY",
          "value": "-9.29%",
          "rating": "D"
        },
        {
          "name": "Turnover",
          "value": "0.42",
          "rating": "C"
        },
        {
          "name": "Gearing Ratio",
          "value": "17.29%",
          "rating": "A"
        }
      ]
    }
  ]
}
```

## Valuation Analysis

| Metric | Current | Industry Ranking | High | Median | Low |
|--------|---------|-----------------|------|--------|-----|
| PE (TTM) | -323.48 | 65/64 | - | - | - |
| PB | 5.25 | 57/64 | 6.21 | 5.51 | 5.12 |
| PS (TTM) | 10.08 | 45/64 | 11.05 | 9.95 | 9.19 |
| Dividend Yield | 0.24% | 47/64 | 0.24% | 0.22% | 0.19% |

## Peer Comparison

| Rank | Name | Profit | Growth | Operation | Security | Cash | Rating |
| --- | --- | --- | --- | --- | --- | --- | --- |
| 01 | APT (688617.SH) | A | B | B | A | B | A |
| 02 | United Imaging Healthcare (688271.SH) | B | A | C | B | B | B |
| 03 | iRay (688301.SH) | B | A | D | C | A | B |
| 04 | YUYUE MEDICAL (002223.SZ) | B | C | C | A | C | B |
| 05 | Insight Lifetech (688712.SH) | B | A | E | A | A | B |

## References

- [Company Overview — Profile, executives, shareholders, business breakdown](https://longbridge.com/en/quote/300753.SZ/overview.md)
- [Financial Reports — Income, balance sheet, cash flow, dividends](https://longbridge.com/en/quote/300753.SZ/norm.md)
- [Related News](https://longbridge.com/en/quote/300753.SZ/news.md)
- [Filings — Company announcements and regulatory filings](https://longbridge.com/en/quote/300753.SZ/filings.md)

---

> **Disclaimer: This article is for reference only and does not constitute any investment advice.**